About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
 Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site         Guidelines at Diagnosis | About Clinical Trials            How to Help!

Patients Against Lymphoma

 

Factors that determine timing and approach | FDA Flow Chart for Frontline Indolent NHL  | 
Treatment Decisions | Watch & Wait

Treatment Overview > Treatment Decisions > 
 
Frontline Treatment Strategy for INDOLENT NHL

Last update: 07/14/2003
Frontline Treatment Strategy for INDOLENT NHL
As you can see in the FDA diagram to the right, there are lots of "ORs", which translates to no standard protocol for frontline indolent NHL.
BACKGROUND INFORMATION ON NON-HODGKIN’S LYMPHOMA, FDA - PDF  | PDF-Help
 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved.